Advertisement
YOU ARE HERE: LAT HomeCollectionsSanofi Company
IN THE NEWS

Sanofi Company

FEATURED ARTICLES
BUSINESS
November 23, 1989 | MARTHA GROVES, TIMES STAFF WRITER
Avon Products, the target of takeover speculation in recent months, said Wednesday that it has agreed to sell its Parfums Stern fragrance unit for $210 million in cash to a company affiliated with Sanofi, a French concern that markets upscale perfumes and beauty products. Parfums Stern handles fragrances, including Oscar de la Renta, Perry Ellis, Uninhibited by Cher and Deneuve.
ARTICLES BY DATE
BUSINESS
March 22, 2006 | From Reuters
Sanofi-Aventis and Bristol-Myers Squibb Co. said they had settled a dispute with generic drug maker Apotex Inc. that could keep patent protection on their multibillion-dollar blood thinner Plavix until 2011. A trial involving the disputed Plavix patent had been set to begin in June in U.S. District Court in New York. Sanofi and Bristol-Myers said they had approached Indian generic drug maker Dr. Reddy's Laboratories Ltd. to discuss a similar settlement.
Advertisement
BUSINESS
November 16, 1999 | Bloomberg News
Gucci Group, one of the world's best-known fashion companies, said it had agreed to buy Sanofi Beaute from businessman Francois Pinault for $697 million to gain the Yves Saint Laurent brand and become the No. 3 luxury-goods maker. Gucci also will pay $70 million to designer Yves Saint Laurent and to Pierre Berge, who headed Sanofi Beaute, and will assume about $267 million in debt. The transaction brings with it several perfume brands, including Fendi, Van Cleef & Arpels and Krizia.
BUSINESS
June 13, 2005 | From Bloomberg News
Sanofi-Aventis' experimental weight-loss drug Acomplia helped obese diabetics control their blood sugar and lose weight in a new study. Acomplia significantly cut the level of HbA1c, a measure of blood-sugar control, to within a manageable range in twice as many patients as those given a placebo, said Marc Cruzel, senior vice president at Paris-based Sanofi. The research was presented at the American Diabetes Assn. meeting in San Diego. U.S.
BUSINESS
March 22, 2006 | From Reuters
Sanofi-Aventis and Bristol-Myers Squibb Co. said they had settled a dispute with generic drug maker Apotex Inc. that could keep patent protection on their multibillion-dollar blood thinner Plavix until 2011. A trial involving the disputed Plavix patent had been set to begin in June in U.S. District Court in New York. Sanofi and Bristol-Myers said they had approached Indian generic drug maker Dr. Reddy's Laboratories Ltd. to discuss a similar settlement.
BUSINESS
June 30, 1994 | From Times Staff and Wire Reports
Sanofi to Sell Winthrop for $450 Million: The drug, cosmetics and perfume unit of French oil group Elf Aquitaine said it will sell nearly all of Sterling Winthrop's diagnostic imaging business to Norway's Hafslund Nycomed for $450 million. The sale follows Sanofi's agreement last week to acquire Sterling Winthrop, the prescription pharmaceutical business of Rochester, N.Y.-based Eastman Kodak, for $1.675 billion.
BUSINESS
April 27, 2004 | From Associated Press
French drug makers Sanofi-Synthelabo and Aventis announced plans Monday to create the world's third-largest pharmaceutical company after Sanofi increased an earlier hostile bid for Aventis. The cash-and-stock deal was valued at $63.2 billion. The agreement ended a bitter three-month struggle for control of Strasbourg-based Aventis, which had also been pursued by Swiss giant Novartis. Late Sunday, European Union regulators approved the deal.
BUSINESS
January 20, 1988 | From the Washington Post
American Home Products, in a victory over two rivals in the battle to acquire A. H. Robins Co., Tuesday broke a 2 1/2-year stalemate over the Richmond, Va., firm's future. The New York conglomerate's winning move was to increase the amount of cash that would be paid quickly to tens of thousands of women who claim injuries from the Dalkon Shield intrauterine contraceptive device.
BUSINESS
April 27, 2004 | From Associated Press
French drug makers Sanofi-Synthelabo and Aventis announced plans Monday to create the world's third-largest pharmaceutical company after Sanofi increased an earlier hostile bid for Aventis. The cash-and-stock deal was valued at $63.2 billion. The agreement ended a bitter three-month struggle for control of Strasbourg-based Aventis, which had also been pursued by Swiss giant Novartis. Late Sunday, European Union regulators approved the deal.
BUSINESS
November 16, 1999 | Bloomberg News
Gucci Group, one of the world's best-known fashion companies, said it had agreed to buy Sanofi Beaute from businessman Francois Pinault for $697 million to gain the Yves Saint Laurent brand and become the No. 3 luxury-goods maker. Gucci also will pay $70 million to designer Yves Saint Laurent and to Pierre Berge, who headed Sanofi Beaute, and will assume about $267 million in debt. The transaction brings with it several perfume brands, including Fendi, Van Cleef & Arpels and Krizia.
BUSINESS
June 12, 1997 | (Bloomberg News)
Redwood City-based Cygnus Inc. said an international arbitration board rejected its claim that France's Sanofi didn't live up to a contract to market a hormone-delivery system in the United States and around the world. Arbitrators from the Tribunal of the International Chamber of Commerce concluded Sanofi didn't fail to properly market FemPatch, which offers low doses of estrogen to menopausal women.
BUSINESS
June 30, 1994 | From Times Staff and Wire Reports
Sanofi to Sell Winthrop for $450 Million: The drug, cosmetics and perfume unit of French oil group Elf Aquitaine said it will sell nearly all of Sterling Winthrop's diagnostic imaging business to Norway's Hafslund Nycomed for $450 million. The sale follows Sanofi's agreement last week to acquire Sterling Winthrop, the prescription pharmaceutical business of Rochester, N.Y.-based Eastman Kodak, for $1.675 billion.
BUSINESS
January 10, 1991 | From Reuters
Eastman Kodak Co. said Wednesday that it will link up its pharmaceutical unit with France's Sanofi SA, in a deal that would create one of the world's top 20 drug companies. Sanofi and Sterling Drug, a unit of Rochester, N.Y.-based Kodak, will set up three joint ventures, opening the huge U.S. market to the French company and strengthening Sterling's presence in Europe. "Our great handicap is we are not present on the American market," Sanofi President Jean-Francois Dehe said.
BUSINESS
January 9, 1991 | From Associated Press
Eastman Kodak Co.'s Sterling Drug subsidiary probably will announce a joint venture today with a French drug company, an industry analyst said Tuesday. Kodak officials will meet with industry analysts today in New York City, Kodak spokesman Paul Allen said. Allen said he couldn't say whether a joint venture between Sterling and Sanofi SA would be announced at the meeting. Jack Kelly, who follows Kodak for Goldman, Sachs & Co.
BUSINESS
June 12, 1997 | (Bloomberg News)
Redwood City-based Cygnus Inc. said an international arbitration board rejected its claim that France's Sanofi didn't live up to a contract to market a hormone-delivery system in the United States and around the world. Arbitrators from the Tribunal of the International Chamber of Commerce concluded Sanofi didn't fail to properly market FemPatch, which offers low doses of estrogen to menopausal women.
BUSINESS
January 8, 1988 | Associated Press
Sanofi S.A. officials said Thursday that they were willing to boost the value of their company's offer to merge with A. H. Robins Co. if necessary to beat out other suitors for the pharmaceutical giant. Separately, the committee representing Robins' shareholders in the company's Chapter 11 bankruptcy reorganization indicated that it was continuing negotiations with all three suitors and hoped to endorse a plan on Friday.
BUSINESS
November 23, 1989 | MARTHA GROVES, TIMES STAFF WRITER
Avon Products, the target of takeover speculation in recent months, said Wednesday that it has agreed to sell its Parfums Stern fragrance unit for $210 million in cash to a company affiliated with Sanofi, a French concern that markets upscale perfumes and beauty products. Parfums Stern handles fragrances, including Oscar de la Renta, Perry Ellis, Uninhibited by Cher and Deneuve.
BUSINESS
January 20, 1988 | From the Washington Post
American Home Products, in a victory over two rivals in the battle to acquire A. H. Robins Co., Tuesday broke a 2 1/2-year stalemate over the Richmond, Va., firm's future. The New York conglomerate's winning move was to increase the amount of cash that would be paid quickly to tens of thousands of women who claim injuries from the Dalkon Shield intrauterine contraceptive device.
Los Angeles Times Articles
|